13 Strategic Shifts in the 2026 STD Diagnostic Market: Point-of-Care Molecular Testing, Multiplex Assays, and Digital Surveillance Integration
As of February 2026, the global diagnostic landscape is undergoing a structural realignment in response to rising infection rates and the demand for decentralized testing, with the Sexually Transmitted Diseases Diagnostic Market emerging as a focal point for molecular innovation. The transition from traditional laboratory-based culture methods to rapid Nucleic Acid Amplification Tests...
0 Kommentare 0 Geteilt 26 Ansichten 0 Bewertungen